Biotech & Pharmaceutical
Tianjin Union Precision Medical Diagnostic Co., Ltd
Tianjin Union Precision Medical Diagnostic Co., Ltd established in 2020, is a third-party medical diagnostic center established by the Institute of Hematology and Blood Diseases Hospital of the Chinese Academy of Medical Sciences. The company focuses on specialized blood testing, relying on the WHO MICM comprehensive diagnostic model to conduct morphological, immunological, genetic, and molecular biological tests, achieving accurate diagnosis and standardized reporting of hematological......
ITAbMed Ltd.
ITAbMed Ltd. is a clinical-stage biotech company located in Shanghai, China.The company was founded in 2020 and is located in Pudong, Shanghai, China.The company is a spin-off entity from the former “Generon BioMed Ltd.".
Tianjin Accendatech Pharmaceutical Technology Co., Ltd.
The company focuses on the research and commercialization of new drugs related to cancer treatment, and has currently achieved six Phase II clinical trials and two Phase I clinical trials. The company's original candidate drug for treating glioma has obtained the Rare Pediatric Disease Designation (RPDD) from the U.S. Food and Drug Administration (FDA), becoming the first original candidate drug from my country to obtain RPDD designation in the United States.
Wuxi Qianpeng Medical Technology Co., Ltd.
Wuxi Qianpeng Medical Technology Co., Ltd. aims to popularize advanced oral health concepts, enabling the Chinese public to have the opportunity and ability to receive necessary oral care. Addressing the current situation in China where there is a shortage of doctors and a large, concentrated number of patients, Qianpeng leverages technology to empower doctors, streamline production and treatment processes, and optimize the industry chain to provide affordable oral care solutions for the public.
Beijing LinkingMed Technology Co., Ltd.
Based on artificial intelligence and cloud computing technologies, the company provides hospital radiotherapy departments and third-party imaging and radiotherapy centers with technical tools and cloud services such as automatic organ delineation, target delineation, automatic radiotherapy planning, and radiotherapy quality control. It is a leading enterprise in the field of artificial intelligence-assisted tumor radiotherapy.
Tianjin Cosychem Technology Co., Ltd.
The company is a national high-tech enterprise and a specialized and innovative "little giant" enterprise integrating chemical technology, chemical engineering technology, and biotechnology. It is committed to becoming the most trusted partner for life science companies through innovative technology. Currently, it can provide one-stop services for the research, development, production, and technology development of aliphatic compounds, core raw materials for mRNA vaccines, and core raw materials
Proteint (Tianjin) Biotech Co., Ltd.
The company focuses on multi-omics research, including disease genomics, proteomics, and metabolomics, and provides doctors, patients, and pharmaceutical companies with a "three-in-one" precision medicine solution that integrates R&D, scientific research, and clinical practice.
Biotech & Pharmaceutical
Tianjin Union Precision Medical Diagnostic Co., Ltd
Tianjin Union Precision Medical Diagnostic Co., Ltd established in 2020, is a third-party medical diagnostic center established by the Institute of Hematology and Blood Diseases Hospital of the Chinese Academy of Medical Sciences. The company focuses on specialized blood testing, relying on the WHO MICM comprehensive diagnostic model to conduct morphological, immunological, genetic, and molecular biological tests, achieving accurate diagnosis and standardized reporting of hematological......
ITAbMed Ltd.
ITAbMed Ltd. is a clinical-stage biotech company located in Shanghai, China.The company was founded in 2020 and is located in Pudong, Shanghai, China.The company is a spin-off entity from the former “Generon BioMed Ltd.".
Tianjin Accendatech Pharmaceutical Technology Co., Ltd.
The company focuses on the research and commercialization of new drugs related to cancer treatment, and has currently achieved six Phase II clinical trials and two Phase I clinical trials. The company's original candidate drug for treating glioma has obtained the Rare Pediatric Disease Designation (RPDD) from the U.S. Food and Drug Administration (FDA), becoming the first original candidate drug from my country to obtain RPDD designation in the United States.
Wuxi Qianpeng Medical Technology Co., Ltd.
Wuxi Qianpeng Medical Technology Co., Ltd. aims to popularize advanced oral health concepts, enabling the Chinese public to have the opportunity and ability to receive necessary oral care. Addressing the current situation in China where there is a shortage of doctors and a large, concentrated number of patients, Qianpeng leverages technology to empower doctors, streamline production and treatment processes, and optimize the industry chain to provide affordable oral care solutions for the public.
Beijing LinkingMed Technology Co., Ltd.
Based on artificial intelligence and cloud computing technologies, the company provides hospital radiotherapy departments and third-party imaging and radiotherapy centers with technical tools and cloud services such as automatic organ delineation, target delineation, automatic radiotherapy planning, and radiotherapy quality control. It is a leading enterprise in the field of artificial intelligence-assisted tumor radiotherapy.
Tianjin Cosychem Technology Co., Ltd.
The company is a national high-tech enterprise and a specialized and innovative "little giant" enterprise integrating chemical technology, chemical engineering technology, and biotechnology. It is committed to becoming the most trusted partner for life science companies through innovative technology. Currently, it can provide one-stop services for the research, development, production, and technology development of aliphatic compounds, core raw materials for mRNA vaccines, and core raw materials
Proteint (Tianjin) Biotech Co., Ltd.
The company focuses on multi-omics research, including disease genomics, proteomics, and metabolomics, and provides doctors, patients, and pharmaceutical companies with a "three-in-one" precision medicine solution that integrates R&D, scientific research, and clinical practice.
Copyright © Tianjin Binhai Venture Capital Investment Management Co., Ltd.
Technical Support: Jinkun Technology. This website supports IPv6
Address: Building B1, OVU China Electronics Technology Innovation Park, 122 Yingshui Road, Xiqing District, Tianjin, China, 300041
Email: office@binhaicapital.com
Partner
Copyright © Tianjin Binhai Venture Capital Management Co., Ltd. This site supports IPv6
Technical Support: Jinkun Technology


